The American Cancer Society National Lung Cancer Roundtable (ACS NLCRT) held the Promoting
Guideline-Concordant Lung Cancer Staging Summit on Thursday, March 2, 2023, in Chicago, Illinois.
Sixty attendees representing 48 organizations from across the country participated in this catalyzing
summit, including lung cancer advocates, clinicians, researchers, and industry partners. The summit
convened leading experts in the lung cancer field to discuss the best practices for lung cancer
staging and improve the delivery of stage-appropriate therapy to advance patient outcomes and
create more lung cancer survivors.
Explore More
Cancer Statistics Center
The ACS’ Cancer Statistics Center website gives the user an opportunity to explore, interact with, and share cancer statistics.
Updates Regarding Biomarker Testing For Non–Small Cell Lung Cancer: Considerations From The National Lung Cancer Roundtable
Updates Regarding Biomarker Testing For Non–Small Cell Lung Cancer: Considerations From The National Lung Cancer Roundtable
Accelerating Uptake of Lung Cancer Screening Summit Executive Summary
The American Cancer Society National Lung Cancer Roundtable (ACS NLCRT) held its inaugural summit on Accelerating Uptake of Lung Cancer Screening on July 19-20, 2022, in Washington, DC. Increasing lung cancer screening has long been a priority of the NLCRT and its members. The goal of the summit was to accelerate the uptake of lung cancer screening by creating a shared understanding of the current state of screening, identifying key challenges and barriers, and developing and prioritizing strategies to build a comprehensive framework that engages key partners with actionable recommendations.